Comments
Dr Reddy’s Laboratories Ltd has launched Succinylcholine Chloride injection, a therapeutic equivalent generic version of Quelicin (Succinylcholine Chloride) injection, in the US market.
The Quelicin brand and generic market had US sales of approximately $74.8 million for the most recent twelve months ending in September 2020 according to IQVIA Health, the Hyderabad-based company said in a release on Thursday.
Dr. Reddy’s Succinylcholine chloride injection is available in multi-dose vials, the release added.
As per the information provided by the company, the product is a short-acting, depolarising skeletal muscle relaxant.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.